A novel packaging system for the generation of helper-free oncolytic MVM vector stocks

Gene Therapy

Volumn 3, Issue 10, 1996, Pages 927-931

  Brandenburger, A ^a   Russell, S ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Cancer gene therapy; MVM; Packaging cell line; Parvoviral vector

Indexed keywords

ONCOLYTIC VIRUS; VIRUS DNA;

ARTICLE; CANCER THERAPY; CHROMOSOME; CONTROLLED STUDY; DNA PACKAGING; EXPRESSION VECTOR; GENE THERAPY; HELPER VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PARVOVIRUS; PLASMID; PRIORITY JOURNAL; TUMOR CELL; VIRUS DNA CELL DNA INTERACTION;

PARVOVIRUS;

EID: 0029997165     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mousset S, Rommeleare J. Minute virus of mice inhibits cell transformation by simian virus 40. Nature 1982; 300: 537-539.
2. Mousset S, Ouadrhiri Y, Caillet-Fauquet P, Rommeleare J. The cytotoxicity of the autonomous parvovirus minute virus of mice nonstructural proteins in FR3T3 rat cells depends on oncogene expression. J Virol 1994; 68: 6446-6453.
3. Dupressoir T et al. Phase I clinical study on the possible use of H-1 parvovirus in cancer treatment. 5th Parvovirus workshop, Crystal River, Florida, 1993.
4. Dupressoir T et al. Inhibition by parvovirus H-1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells. Cancer Res 1989; 49: 3203-3208.
5. Brandenburger A, Legendre D, Avalosse B, Rommeleare J, NS-1 and NS-2 proteins may act synergistically in the cytopathogenicity of parvovirus MVM(p). J Virol 1990; 174: 576-584.
6. Naeger LK, Salomé N, Pintel DJ. NS2 is required for efficient translation of viral mRNA in minute virus of mice-infected murine cells. J Virol 1993; 67: 1034-1043.
7. Caillet-Fauquet P et al. Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding nonstructural proteins. EMBO J 1990; 9: 2989-2995.
8. Reitz BA, Ramabhadran TV, Pintel D. The P39 promoter of minute virus of mice directs high levels of bovine growth hormone gene expression in the bovine papilloma virus shuttle vector. Gene 1987, 56: 297-300.
9. Dupont F et al. Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein. J Virol 1994; 68: 1397-1406.
10. Legendre D, Rommeleare J. Terminal regions of the NS-1 protein of the parvovirus minute virus of mice are involved in cytotoxicity and promoter trans inhibition. J Virol 1992; 66: 5705-5713.
11. Merchlinski MJ et al. Construction of an infective molecular clone of the autonomous parvovirus minute virus of mice. J Virol 1983; 47: 227-232.
12. Russell SJ et al. Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J Virol 1992; 66: 2821-2828.
13. Maxwell IH et al. Recombinant LuIII autonomous parvovirus as a transient transducing vector for human cells. Hum Gene Ther 1993; 4: 441-450.
14. Cornelis JJ et al. Transformation of human fibroblasts by ionizing radiation, a chemical carcinogen, or simian virus 40 correlates with an increase in susceptibility to the autonomous parvovirus H-1 virus and minute virus of mice. J Virol 1988; 62: 1679-1686.
15. Salvino R et al. Two spatially distinct genetic elements constitute a bipartite DNA replication origin in the minute virus of mice genome. J Virol 1991; 65: 1352-1363.